Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2013

Aug 8, 2013

35146_dirs_2013-08-08_d4078f1c-41a3-4265-89f5-823d8d1e260d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2013-08-05

Reporting Person: Steinhart Richard I (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-05 Restricted common stock A 25000 $0.00 Acquired 25000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-05 Stock Options $0.92 A 141304 Acquired 2023-08-05 Common Stock (141304) Direct
2013-08-05 Stock Options $0.92 A 15000 Acquired 2023-08-05 Common Stock (15000) Direct

Footnotes

F1: Restricted stock will vest according to the following schedule:
11/5/13 6,250 shares
2/5/14 6,250 shares
5/5/14 6,250 shares
8/5/14 6,250 shares

F2: The stock option grant will vest as follows:
11/5/2013 35,326 options
2/5/14 35,326 options
5/5/14 35,326 options
8/5/14 35,326 options

F3: The stock option grant will vest as follows
8/5/14 3,750 options
8/5/15 3,750 options
8/5/16 3,750 options
8/5/17 3,750 options